{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:32:45Z","timestamp":1791246765770,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/bmt.2017.161","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T09:40:23Z","timestamp":1501494023000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":331,"title":["Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation"],"prefix":"10.1038","volume":"53","author":[{"given":"S","family":"Corbacioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-H","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Guengoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pagliuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sedlacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-W","family":"Sykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Toporski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Trigoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Vetteranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wachowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wallhult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Yesilipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"BFbmt2017161_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/pbc.25764","volume":"63","author":"H Boztug","year":"2016","unstructured":"Boztug H, Sykora KW, Slatter M, Zecca M, Veys P, Lankester A et al. European Society for Blood and Marrow Transplantation analysis of treosulfan conditioning before hematopoietic stem cell transplantation in children and adolescents with hematological malignancies. Pediatr Blood Cancer 2016; 63: 139\u2013148.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017161_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","volume":"23","author":"A Helmy","year":"2006","unstructured":"Helmy A . Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther 2006; 23: 11\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFbmt2017161_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM . Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol 2014; 4: 332\u2013346.","journal-title":"J Clin Exp Hepatol"},{"key":"BFbmt2017161_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2011.65","volume":"46","author":"E Carreras","year":"2011","unstructured":"Carreras E, Diaz-Ricart M . The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplant 2011; 46: 1495\u20131502.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.leukres.2006.07.005","volume":"31","author":"JM McKoy","year":"2007","unstructured":"McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM et al. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project. Leuk Res 2007; 31: 599\u2013604.","journal-title":"Leuk Res"},{"key":"BFbmt2017161_CR6","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","volume":"102","author":"M Wadleigh","year":"2003","unstructured":"Wadleigh M, Richardson PG, Zahrieh D, Lee SJ, Cutler C, Ho V et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood 2003; 102: 1578\u20131582.","journal-title":"Blood"},{"key":"BFbmt2017161_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.clml.2012.12.003","volume":"13","author":"P Kebriaei","year":"2013","unstructured":"Kebriaei P, Wilhelm K, Ravandi F, Brandt M, de Lima M, Ciurea S et al. Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin. Clin Lymphoma Myeloma Leuk 2013; 13: 296\u2013301.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFbmt2017161_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11531840-000000000-00000","volume":"12","author":"MG Cefalo","year":"2010","unstructured":"Cefalo MG, Maurizi P, Arlotta A, Scalzone M, Attina G, Ruggiero A et al. Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies. Paediatr Drugs 2010; 12: 277\u2013284.","journal-title":"Paediatr Drugs"},{"key":"BFbmt2017161_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/pbc.22841","volume":"57","author":"S Cesaro","year":"2011","unstructured":"Cesaro S, Spiller M, Sartori MT, Alaggio R, Peruzzo M, Saggiorato G et al. Veno-occlusive disease in pediatric patients affected by Wilms tumor. Pediatr Blood Cancer 2011; 57: 258\u2013261.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017161_CR10","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/pbc.26074","volume":"63","author":"KJ Nazemi","year":"2016","unstructured":"Nazemi KJ, Shen V, Finlay JL, Boyett J, Kocak M, Lafond D et al. High incidence of veno-ccclusive disease with myeloablative chemotherapy following craniospinal irradiation in children with newly diagnosed high-risk CNS embryonal tumors: a report from the Children's Oncology Group (CCG-99702). Pediatr Blood Cancer 2016; 63: 1563\u20131570.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017161_CR11","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1182\/blood-2009-07-230656","volume":"115","author":"LC Stork","year":"2010","unstructured":"Stork LC, Matloub Y, Broxson E, La M, Yanofsky R, Sather H et al. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. Blood 2010; 115: 2740\u20132748.","journal-title":"Blood"},{"issue":"1","key":"BFbmt2017161_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/tpj.2016.65","volume":"18","author":"P Huezo-Diaz Curtis","year":"2016","unstructured":"Huezo-Diaz Curtis P, Uppugunduri CR, Muthukumaran J, Rezgui MA, Peters C, Bader P et al. Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation. Pharmacogenomics J (e-pub ahead of print 25 October 2016; doi: 10.1038\/tpj.2016.65).","journal-title":"The Pharmacogenomics Journal"},{"key":"BFbmt2017161_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00432-014-1857-2","volume":"141","author":"C Seifert","year":"2015","unstructured":"Seifert C, Wittig S, Arndt C, Gruhn B . Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol 2015; 141: 877\u2013885.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFbmt2017161_CR14","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1182\/blood-2015-10-676114","volume":"127","author":"M Palomo","year":"2016","unstructured":"Palomo M, Mir E, Rovira M, Escolar G, Carreras E, Diaz-Ricart M . What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance. Blood 2016; 127: 1719\u20131727.","journal-title":"Blood"},{"key":"BFbmt2017161_CR15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 2012; 379: 1301\u20131309.","journal-title":"Lancet"},{"key":"BFbmt2017161_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010; 16: 157\u2013168.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR17","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","volume":"127","author":"PG Richardson","year":"2016","unstructured":"Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 2016; 127: 1656\u20131665.","journal-title":"Blood"},{"key":"BFbmt2017161_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","volume":"5","author":"JL Lee","year":"1999","unstructured":"Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB . Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 1999; 5: 306\u2013315.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR19","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.bbmt.2007.08.002","volume":"13","author":"E Carreras","year":"2007","unstructured":"Carreras E, Rosinol L, Terol MJ, Alegre A, de Arriba F, Garcia-Larana J et al. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Biol Blood Marrow Transplant 2007; 13: 1448\u20131454.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR20","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","volume":"21","author":"A Akil","year":"2015","unstructured":"Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015; 21: 1739\u20131745.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/pbc.22314","volume":"54","author":"A Iguchi","year":"2010","unstructured":"Iguchi A, Kobayashi R, Kaneda M, Kobayashi K . Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation. Pediatr Blood Cancer 2010; 54: 437\u2013443.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017161_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.bbmt.2010.02.016","volume":"16","author":"C Cutler","year":"2010","unstructured":"Cutler C, Kim HT, Ayanian S, Bradwin G, Revta C, Aldridge J et al. Prediction of veno-occlusive disease using biomarkers of endothelial injury. Biol Blood Marrow Transplant 2010; 16: 1180\u20131185.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1160\/TH04-09-0621","volume":"93","author":"MT Sartori","year":"2005","unstructured":"Sartori MT, Spiezia L, Cesaro S, Messina C, Paris M, Pillon M et al. Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost 2005; 93: 682\u2013689.","journal-title":"Thromb Haemost"},{"key":"BFbmt2017161_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.bmt.1702624","volume":"26","author":"S Tanikawa","year":"2000","unstructured":"Tanikawa S, Mori S, Ohhashi K, Akiyama H, Sasaki T, Kaku H et al. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study. Bone Marrow Transplant 2000; 26: 881\u2013886.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00261-001-0097-5","volume":"27","author":"KJ Mortele","year":"2002","unstructured":"Mortele KJ, Van Vlierberghe H, Wiesner W, Ros PR . Hepatic veno-occlusive disease: MRI findings. Abdom Imaging 2002; 27: 523\u2013526.","journal-title":"Abdom Imaging"},{"key":"BFbmt2017161_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00007890-200207150-00011","volume":"74","author":"N Lassau","year":"2002","unstructured":"Lassau N, Auperin A, Leclere J, Bennaceur A, Valteau-Couanet D, Hartmann O . Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease. Transplantation 2002; 74: 60\u201366.","journal-title":"Transplantation"},{"key":"BFbmt2017161_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s002470000373","volume":"31","author":"MB McCarville","year":"2001","unstructured":"McCarville MB, Hoffer FA, Howard SC, Goloubeva O, Kauffman WM . Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings. Pediatr Radiol 2001; 31: 102\u2013105.","journal-title":"Pediatr Radiol"},{"key":"BFbmt2017161_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BFbmt2017161_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED . Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116\u2013122.","journal-title":"Hepatology"},{"key":"BFbmt2017161_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BFbmt2017161_CR31","first-page":"197","volume":"10","author":"HM Shulman","year":"1992","unstructured":"Shulman HM, Hinterberger W . Hepatic veno-occlusive disease\u2014liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197\u2013214.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2015; 50: 781\u2013789.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR33","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998; 92: 3599\u20133604.","journal-title":"Blood"},{"key":"BFbmt2017161_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","volume":"17","author":"E Carreras","year":"2011","unstructured":"Carreras E, Diaz-Beya M, Rosinol L, Martinez C, Fernandez-Aviles F, Rovira M . The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 2011; 17: 1713\u20131720.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/bmt.2015.283","volume":"51","author":"K Yakushijin","year":"2016","unstructured":"Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transplant 2016; 51: 403\u2013409.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","volume":"32","author":"CC Barker","year":"2003","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS . Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79\u201387.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR37","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396\u20131404.","journal-title":"Haematologica"},{"key":"BFbmt2017161_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","volume":"38","author":"S Corbacioglu","year":"2006","unstructured":"Corbacioglu S, Honig M, Lahr G, Stohr S, Berry G, Friedrich W et al. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant 2006; 38: 547\u2013553.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR39","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737\u2013744.","journal-title":"Blood"},{"key":"BFbmt2017161_CR40","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren DL, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in 88 patients post stem cell transplant with severe veno-occlusive disease and multi-system organ failure; response without significant toxicity in a high risk population and factors predictive of outcome. Blood 2002; 100: 4337\u20134343.","journal-title":"Blood"},{"key":"BFbmt2017161_CR41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","volume":"16","author":"PG Richardson","year":"2010","unstructured":"Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J et al. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multi-organ failure post stem cell transplantation: a multi-center, randomized, dose-finding trial. Biol Blood Marrow Transplant 2010; 16: 1005\u20131017.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1399-0012.2012.01604.x","volume":"26","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang Y, Huang H . Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Clin Transplant 2012; 26: 511\u2013519.","journal-title":"Clin Transplant"},{"key":"BFbmt2017161_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","volume":"40","author":"F Dignan","year":"2007","unstructured":"Dignan F, Gujral D, Ethell M, Evans S, Treleaven J, Morgan G et al. Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. Bone Marrow Transplant 2007; 40: 79\u201382.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR44","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1182\/blood-2003-10-3612","volume":"103","author":"B Versluys","year":"2004","unstructured":"Versluys B, Bhattacharaya R, Steward C, Cornish J, Oakhill A, Goulden N . Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure. Blood 2004; 103: 1968.","journal-title":"Blood"},{"key":"BFbmt2017161_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347\u2013354.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR46","first-page":"3412","volume":"128","author":"P Richardson","year":"2016","unstructured":"Richardson P, Smith A, Triplett B, Kernan N, Grupp S, Antin J et al. Treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) post-hematopoietic stem cell transplantation (HSCT) in patients with acute leukemias: a subgroup analysis from the defibrotide expanded-access program ASH . Annual Meeting Abstracts 2016; 128: 3412.","journal-title":"Annual Meeting Abstracts"},{"key":"BFbmt2017161_CR47","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","volume":"22","author":"S Corbacioglu","year":"2016","unstructured":"Corbacioglu S, Carreras E, Mohty M, Pagliuca A, Boelens JJ, Damaj G et al. Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program. Biol Blood Marrow Transplant 2016; 22: 1874\u20131882.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR49","first-page":"66","volume":"128","author":"S Grupp","year":"2016","unstructured":"Grupp S, Smith A, Triplett B, Kernan N, Antin J, Lehmann L et al. Timingof initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome post-hematopoietic stem cell transplantation: exploratory age-group analysis from an expanded access study. ASH, Annual Meeting Abstracts 2016; 128: 66.","journal-title":"ASH, Annual Meeting Abstracts"},{"key":"BFbmt2017161_CR50","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 2016; 51: 906\u2013912.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1182\/blood-2003-04-1311","volume":"103","author":"WJ Hogan","year":"2004","unstructured":"Hogan WJ, Maris M, Storer B, Sandmaier BM, Maloney DG, Schoch HG et al. Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood 2004; 103: 78\u201384.","journal-title":"Blood"},{"key":"BFbmt2017161_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/bmt.2014.7","volume":"49","author":"A Nagler","year":"2014","unstructured":"Nagler A, Labopin M, Berger R, Bunjes D, Campos A, Socie G et al. Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome. Bone Marrow Transplant 2014; 49: 628\u2013633.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR53","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","volume":"3","author":"IH Bartelink","year":"2016","unstructured":"Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J et al. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Lancet Haematol 2016; 3: e526\u2013e536.","journal-title":"Lancet Haematol"},{"key":"BFbmt2017161_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/tpj.2013.38","volume":"14","author":"CR Uppugunduri","year":"2014","unstructured":"Uppugunduri CR, Rezgui MA, Diaz PH, Tyagi AK, Rousseau J, Daali Y et al. The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation. Pharmacogenomics J 2014; 14: 263\u2013271.","journal-title":"Pharmacogenomics J"},{"key":"BFbmt2017161_CR55","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1182\/blood-2013-08-519009","volume":"122","author":"C Bredeson","year":"2013","unstructured":"Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM et al. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. Blood 2013; 122: 3871\u20133878.","journal-title":"Blood"},{"key":"BFbmt2017161_CR56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/petr.12236","volume":"18","author":"Y Okamoto","year":"2014","unstructured":"Okamoto Y, Nagatoshi Y, Kosaka Y, Kikuchi A, Kato S, Kigasawa H et al. Prospective pharmacokinetic study of intravenous busulfan in hematopoietic stem cell transplantation in 25 children. Pediatr Transplant 2014; 18: 294\u2013301.","journal-title":"Pediatr Transplant"},{"key":"BFbmt2017161_CR57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1399-3046.2011.01529.x","volume":"15","author":"R Malar","year":"2011","unstructured":"Malar R, Sjoo F, Rentsch K, Hassan M, Gungor T . Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients. Pediatr Transplant 2011; 15: 580\u2013588.","journal-title":"Pediatr Transplant"},{"key":"BFbmt2017161_CR58","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.ejca.2012.05.020","volume":"48","author":"GJ Veal","year":"2012","unstructured":"Veal GJ, Nguyen L, Paci A, Riggi M, Amiel M, Valteau-Couanet D et al. Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1\/SIOPEN trial. Eur J Cancer 2012; 48: 3063\u20133072.","journal-title":"Eur J Cancer"},{"key":"BFbmt2017161_CR59","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood.V99.9.3458","volume":"99","author":"AS Schulz","year":"2002","unstructured":"Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood 2002; 99: 3458\u20133460.","journal-title":"Blood"},{"key":"BFbmt2017161_CR60","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.1542\/peds.2005-1789","volume":"117","author":"M Ouachee-Chardin","year":"2006","unstructured":"Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 2006; 117: e743\u2013e750.","journal-title":"Pediatrics"},{"key":"BFbmt2017161_CR61","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","volume":"40","author":"DK Cheuk","year":"2007","unstructured":"Cheuk DK, Wang P, Lee TL, Chiang AK, Ha SY, Lau YL et al. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 935\u2013944.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bmt.1703340","volume":"29","author":"CK Li","year":"2002","unstructured":"Li CK, Shing MM, Chik KW, Lee V, Leung TF, Cheung AY et al. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome. Bone Marrow Transplant 2002; 29: 101\u2013105.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbmt.2007.05.004","volume":"13","author":"V Mathews","year":"2007","unstructured":"Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 889\u2013894.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/sj.bmt.1703393","volume":"29","author":"B Horn","year":"2002","unstructured":"Horn B, Reiss U, Matthay K, McMillan A, Cowan M . Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma. Bone Marrow Transplant 2002; 29: 409\u2013415.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/pbc.23155","volume":"58","author":"M Qayed","year":"2012","unstructured":"Qayed M, Chiang KY, Ricketts R, Alazraki A, Tahvildari A, Haight A et al. Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma. Pediatr Blood Cancer 2012; 58: 448\u2013452.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017161_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/bmt.2014.256","volume":"50","author":"N Yasui","year":"2015","unstructured":"Yasui N, Kawamoto H, Fujiwara M, Aihara Y, Ogawa C, Hosono A et al. High-dose chemotherapy for high-risk retinoblastoma: clinical course and outcome of 14 cases in the National Cancer Center, Japan. Bone Marrow Transplant 2015; 50: 221\u2013224.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/pbc.20338","volume":"46","author":"M Elli","year":"2006","unstructured":"Elli M, Pinarli FG, Dagdemir A, Acar S . Veno-occlusive disease of the liver in a child after chemotherapy for brain tumor. Pediatr Blood Cancer 2006; 46: 521\u2013523.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2017161_CR68","first-page":"843","volume":"26","author":"ML Sulis","year":"2004","unstructured":"Sulis ML, Bessmertny O, Granowetter L, Weiner M, Kelly KM . Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma. J Pediatr Hematol Oncol 2004; 26: 843\u2013846.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFbmt2017161_CR69","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/s-2008-1072380","volume":"10","author":"P Czauderna","year":"2000","unstructured":"Czauderna P, Katski K, Kowalczyk J, Kurylak A, Lopatka B, Skotnicka-Klonowicz G et al. Venoocclusive liver disease (VOD) as a complication of Wilms' tumour management in the series of consecutive 206 patients. Eur J Pediatr Surg 2000; 10: 300\u2013303.","journal-title":"Eur J Pediatr Surg"},{"key":"BFbmt2017161_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbmt.2006.10.026","volume":"13","author":"T Schechter","year":"2007","unstructured":"Schechter T, Finkelstein Y, Doyle J, Verjee Z, Moretti M, Koren G et al. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 307\u2013314.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR71","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","volume":"24","author":"HC Toh","year":"1999","unstructured":"Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR . Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 1999; 24: 891\u2013895.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR72","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3109\/10428194.2012.661052","volume":"53","author":"RK Pai","year":"2012","unstructured":"Pai RK, van Besien K, Hart J, Artz AS, O'Donnell PH . Clinicopathologic features of late-onset veno-occlusive disease\/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant. Leuk Lymphoma 2012; 53: 1552\u20131557.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2017161_CR73","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","volume":"21","author":"KC Myers","year":"2015","unstructured":"Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S . Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21: 379\u2013381.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR74","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1182\/blood.V124.21.5849.5849","volume":"124","author":"J Naples","year":"2014","unstructured":"Naples J, Skeens M, Bajwa R . Anicteric hepatic veno-occlusive disease after hematopoietic stem cell transplantation in children. Blood 2014; 124: 5849\u20135849.","journal-title":"Blood"},{"key":"BFbmt2017161_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjh.13215","volume":"168","author":"E Carreras","year":"2015","unstructured":"Carreras E . How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation. Br J Haematol 2015; 168: 481\u2013491.","journal-title":"Br J Haematol"},{"key":"BFbmt2017161_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01695888","volume":"66","author":"E Carreras","year":"1993","unstructured":"Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol 1993; 66: 77\u201380.","journal-title":"Ann Hematol"},{"key":"BFbmt2017161_CR77","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","volume":"142","author":"E Hod","year":"2008","unstructured":"Hod E, Schwartz J . Platelet transfusion refractoriness. Br J Haematol 2008; 142: 348\u2013360.","journal-title":"Br J Haematol"},{"key":"BFbmt2017161_CR78","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V67.6.1773.1773","volume":"67","author":"B Rio","year":"1986","unstructured":"Rio B, Andreu G, Nicod A, Arrago JP, Dutrillaux F, Samama M et al. Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773\u20131776.","journal-title":"Blood"},{"key":"BFbmt2017161_CR79","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005\u20133020.","journal-title":"Blood"},{"key":"BFbmt2017161_CR80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/theoncologist.1-6-371","volume":"1","author":"RA Nash","year":"1996","unstructured":"Nash RA, Gooley T, Davis C, Appelbaum FR . The problem of thrombocytopenia after hematopoietic stem cell transplantation. Oncologist 1996; 1: 371\u2013380.","journal-title":"Oncologist"},{"key":"BFbmt2017161_CR81","first-page":"427","volume":"36","author":"F Norol","year":"1993","unstructured":"Norol F, Kuentz M, Cordonnier C, Beaujean F, Haiouin C, Vernant JP et al. [Influence of clinical status on the efficacy of stored platelet transfusion]. Rev Fr Transfus Hemobiol 1993; 36: 427\u2013437.","journal-title":"Rev Fr Transfus Hemobiol"},{"key":"BFbmt2017161_CR82","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1148\/radiology.184.3.1509050","volume":"184","author":"SC Hommeyer","year":"1992","unstructured":"Hommeyer SC, Teefey SA, Jacobson AF, Higano CS, Bianco JA, Colacurcio CJ et al. Venocclusive disease of the liver: prospective study of US evaluation. Radiology 1992; 184: 683\u2013686.","journal-title":"Radiology"},{"key":"BFbmt2017161_CR83","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1148\/radiol.10100025","volume":"258","author":"SY Mahgerefteh","year":"2011","unstructured":"Mahgerefteh SY, Sosna J, Bogot N, Shapira MY, Pappo O, Bloom AI . Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology 2011; 258: 660\u2013671.","journal-title":"Radiology"},{"key":"BFbmt2017161_CR84","first-page":"21","volume":"11","author":"E Carreras","year":"1993","unstructured":"Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993; 11: 21\u201326.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR85","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/00007890-199504150-00017","volume":"59","author":"HM Shulman","year":"1995","unstructured":"Shulman HM, Gooley T, Dudley MD, Kofler T, Feldman R, Dwyer D et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 1015\u20131022.","journal-title":"Transplantation"},{"key":"BFbmt2017161_CR86","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2214\/ajr.164.6.7754881","volume":"164","author":"SA Teefey","year":"1995","unstructured":"Teefey SA, Brink JA, Borson RA, Middleton WD . Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. AJR Am J Roentgenol 1995; 164: 1397\u20131401.","journal-title":"AJR Am J Roentgenol"},{"key":"BFbmt2017161_CR87","doi-asserted-by":"publisher","first-page":"575","DOI":"10.7863\/jum.1997.16.9.575","volume":"16","author":"MJ Sharafuddin","year":"1997","unstructured":"Sharafuddin MJ, Foshager MC, Steinbuch M, Weisdorf DJ, Hunter DW . Sonographic findings in bone marrow transplant patients with symptomatic hepatic venoocclusive disease. J Ultrasound Med 1997; 16: 575\u2013586.","journal-title":"J Ultrasound Med"},{"key":"BFbmt2017161_CR88","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2214\/ajr.150.2.289","volume":"150","author":"JS Kriegshauser","year":"1988","unstructured":"Kriegshauser JS, Charboneau JW, Letendre L . Hepatic venocclusive disease after bone-marrow transplantation: diagnosis with duplex sonography. AJR Am J Roentgenol 1988; 150: 289\u2013290.","journal-title":"AJR Am J Roentgenol"},{"key":"BFbmt2017161_CR89","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/sj.bmt.1705170","volume":"36","author":"M Hashiguchi","year":"2005","unstructured":"Hashiguchi M, Okamura T, Yoshimoto K, Ono N, Imamura R, Yakushiji K et al. Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1071\u20131075.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2017161_CR90","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.bbmt.2016.07.011","volume":"22","author":"MA Skeens","year":"2016","unstructured":"Skeens MA, McArthur J, Cheifetz IM, Duncan C, Randolph AG, Stanek J et al. Highvariability in the reported management of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016; 22: 1823\u20131828.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017161_CR91","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1097\/MPH.0b013e3182025236","volume":"33","author":"B Oshrine","year":"2011","unstructured":"Oshrine B, Lehmann LE, Duncan CN . Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2011; 33: e92\u2013e97.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFbmt2017161_CR92","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1182\/blood-2014-03-551630","volume":"123","author":"N Chao","year":"2014","unstructured":"Chao N . How I treat sinusoidal obstruction syndrome. Blood 2014; 123: 4023\u20134026.","journal-title":"Blood"},{"key":"BFbmt2017161_CR93","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","volume":"11","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB . Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729\u20131736.","journal-title":"J Clin Oncol"},{"key":"BFbmt2017161_CR94","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A et al. BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 2013; 163: 444\u2013457.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bmt2017161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bmt2017161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bmt2017161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T17:53:43Z","timestamp":1719338023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2017161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFbmt2017161"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.161","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]},"assertion":[{"value":"16 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}